Skip to Main Content

Here you can browse the complete list of publications for studies listed on CDAS.

Studies
Publication Year
Results: 1157 (Showing 1 to 20)
Title PubMed Id Authors Journal Abbreviation Year Studies
Modeling oral cancer screening in the United States population. 34864525 Cramer JD, Grauer J Oral Oncol 2022 NLST
Long-term Outcomes After Lung Cancer Resection in Smokers: Analysis of the National Lung Screening Trial. 34591149 Sesti J, Decker J, Bell J, Nguyen A, Lackey A, Turner AL, Hilden P, Paul S World J Surg 2022 NLST
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. 33398198 Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, Schumacher FR, Olama AAA, Benlloch S, Dadaev T, Brook MN, Sahimi A, Hoffmann TJ, Takahashi A, Matsuda K, Momozawa Y, Fujita M, Muir K, Lophatananon A, Wan P, Le Marchand L, Wilkens LR, Steve… Nat Genet 2021 PLCO
Genetic variants in the cholesterol biosynthesis pathway genes and risk of prostate cancer. 33444688 Cheng Y, Meng Y, Li S, Cao D, Ben S, Qin C, Hua L, Cheng G Gene 2021 PLCO
Deep convolutional neural networks to predict cardiovascular risk from computed tomography. 33514711 Zeleznik R, Foldyna B, Eslami P, Weiss J, Alexander I, Taron J, Parmar C, Alvi RM, Banerji D, Uno M, Kikuchi Y, Karady J, Zhang L, Scholtz JE, Mayrhofer T, Lyass A, Mahoney TF, Massaro JM, Vasan RS, Douglas PS, Hoffmann U, Lu MT, Aerts HJWL Nat Commun 2021 NLST
Wavelet decomposition facilitates training on small datasets for medical image classification by deep learning. 33502624 Masquelin AH, Cheney N, Kinsey CM, Bates JHT Histochem Cell Biol 2021 NLST
Assessing Lung Cancer Absolute Risk Trajectory based on a Polygenic Risk Model. 33472890 Hung RJ, Warkentin MT, Brhane Y, Chatterjee N, Christiani DC, Landi MT, Caporaso NE, Liu G, Johansson M, Albanes D, Le Marchand L, Tardon A, Rennert G, Bojesen SE, Chen C, Field JK, Kiemeney LA, Lazarus P, Zienolddiny S, Lam S, Andrew AS, Arnold SM,… Cancer Res 2021 NLST
Using Prediction-Models to Reduce Persistent Racial/Ethnic Disparities in Draft 2020 USPSTF Lung-Cancer Screening Guidelines. 33399825 Landy R, Young CD, Skarzynski M, Cheung LC, Berg CD, Rivera MP, Robbins HA, Chaturvedi AK, Katki HA J Natl Cancer Inst 2021 NLST
Selenium Kinetics in Humans Change Following 2 years of Supplementation with Selenomethionine Patterson BH, Combs GF Jr., Taylor PR, Patterson KY, Moler JE, Wastney ME Front Endocrinol (Lausanne) 2021 Selenium
Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study. 33038280 Dimou NL, Papadimitriou N, Mariosa D, Johansson M, Brennan P, Peters U, Chanock SJ, Purdue M, Bishop DT, Gago-Dominquez M, Giles GG, Moreno V, Platz EA, Tangen CM, Wolk A, Zheng W, Wu X, Campbell PT, Giovannucci E, Lin Y, CCFR, Endometrial Cancer As… Int J Cancer 2021 PLCO
Smoking modifies pancreatic cancer risk loci on 2q21.3. 33574088 Mocci E, Kundu P, Wheeler W, Arslan AA, Beane Freeman LE, Bracci PM, Brennan P, Canzian F, Du M, Gallinger S, Giles GG, Goodman PJ, Kooperberg C, Le Marchand L, Neale RE, Shu XO, Visvanathan K, White E, Zheng W, Albanes D, Andreotti G, Babic A, Baml… Cancer Res 2021 PLCO
A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. 33517887 López de Maturana E, Rodríguez JA, Alonso L, Lao O, Molina-Montes E, Martín-Antoniano IA, Gómez-Rubio P, Lawlor R, Carrato A, Hidalgo M, Iglesias M, Molero X, Löhr M, Michalski C, Perea J, O'Rorke M, Barberà VM, Tardón A, Farré A, Muñoz-Bellvís L, C… Genome Med 2021 PLCO
Estimating the Impact of Extended Delay to Surgery for Stage I Non-Small-Cell Lung Cancer on Survival: Lessons for the COVID-19 Pandemic. 33630435 Mayne NR, Elser H, Darling AJ, Raman V, Liou D, Colson Y, D'Amico TA, Yang CJ Ann Surg 2021 NLST
Lung Cancer Screening with Low Dose Computed Tomography in Patients With and Without Prior History of Cancer in the National Lung Screening Trial. 33581343 Henderson LM, Durham DD, Tammemägi MC, Benefield T, Marsh MW, Rivera MP J Thorac Oncol 2021 NLST
Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening. 33574075 Schreuder A, Jacobs C, Lessmann N, Broeders MJ, Silva M, Išgum I, de Jong PA, Sverzellati N, Prokop M, Pastorino U, Schaefer-Prokop CM, van Ginneken B Eur Respir J 2021 NLST
Lung cancer prediction by Deep Learning to identify benign lung nodules. 33556604 Heuvelmans MA, van Ooijen PMA, Ather S, Silva CF, Han D, Heussel CP, Hickes W, Kauczor HU, Novotny P, Peschl H, Rook M, Rubtsov R, von Stackelberg O, Tsakok MT, Arteta C, Declerck J, Kadir T, Pickup L, Gleeson F, Oudkerk M Lung Cancer 2021 NLST
Do competing causes of mortality contribute to overdiagnosis in lung cancer screening? 33445120 Durham DD, Croswell JM, Marcus PM Lung Cancer 2021 NLST
Clinical Significance of Lung-RADS Category 3 lesions in the National Lung Screening Trial. 33722708 Han DH, Duan F, Wu Y, Goo JM, Kim HY, Patz EF J Thorac Oncol 2021 NLST
Glycemic Index, Glycemic Load, and Risk of Ovarian Cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cohort. 33693724 Mongiovi JM, Freudenheim JL, Moysich KB, McCann SE J Nutr 2021 PLCO
Deep Learning to Estimate Biological Age From Chest Radiographs. 33744131 Raghu VK, Weiss J, Hoffmann U, Aerts HJWL, Lu MT JACC Cardiovasc Imaging 2021 PLCO, NLST